Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence van Hunsel

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Drug Safety|January 12, 2022
Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event ReportsCorine Ekhart, Florence van Hunsel, Eugène van Puijenbroek, et al.
Frontiers in Pharmacology|November 30, 2019
Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database VigibaseFlorence van Hunsel, Sonja van de Koppel, Souad Skalli, et al.
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|April 2, 2024
Breastfeeding-Related Adverse Drug Reactions of Triptans: A Descriptive Analysis Using Four Pharmacovigilance DatabasesMaartje Conijn, Veronique Maas, Miranda van Tuyl, et al.
Plos One|March 3, 2022
Evaluation of pharmacovigilance systems for reporting medication errors in Africa and the role of patients using a mixed-methods approachGeorge Tsey Sabblah, Seth Kwaku Seaneke, Mawuli Kushitor, et al.
Drug Safety|September 22, 2017
Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring CentreSarah Watson, Rebecca E Chandler, Henric Taavola, et al.
Frontiers in Immunology|February 16, 2023
Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literatureJanneke W Duijster, Thomas Lieber, Silvia Pacelli, et al.
Vaccine|September 6, 2025
A review of methodologic & data considerations for vaccine safety surveillance in the wake of the COVID-19 pandemicKatherine E Mues, Cindy Ke Zhou, Jennifer E Gerber, et al.
Acta Dermato-Venereologica|January 28, 2022
Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance CenterLinda Davidson, Juul M P A Van den Reek, Florence Van Hunsel, et al.
British Journal of Clinical Pharmacology|May 31, 2020
Opportunities for changes in the drug product design to enhance medication safety in older people: Evaluation of a national public portal for medication incidentsFatma Karapinar-Çarkit, Patricia M L A van den Bemt, Mariam Sadik, et al.
Drug Safety|January 14, 2026
Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus GroupFlorence van Hunsel, Samantha Lane, Dawn Cooper, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Drug Safety|January 12, 2022
Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event ReportsCorine Ekhart, Florence van Hunsel, Eugène van Puijenbroek, et al.
Frontiers in Pharmacology|November 30, 2019
Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database VigibaseFlorence van Hunsel, Sonja van de Koppel, Souad Skalli, et al.
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|April 2, 2024
Breastfeeding-Related Adverse Drug Reactions of Triptans: A Descriptive Analysis Using Four Pharmacovigilance DatabasesMaartje Conijn, Veronique Maas, Miranda van Tuyl, et al.
Plos One|March 3, 2022
Evaluation of pharmacovigilance systems for reporting medication errors in Africa and the role of patients using a mixed-methods approachGeorge Tsey Sabblah, Seth Kwaku Seaneke, Mawuli Kushitor, et al.
Drug Safety|September 22, 2017
Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring CentreSarah Watson, Rebecca E Chandler, Henric Taavola, et al.
Frontiers in Immunology|February 16, 2023
Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literatureJanneke W Duijster, Thomas Lieber, Silvia Pacelli, et al.
Vaccine|September 6, 2025
A review of methodologic & data considerations for vaccine safety surveillance in the wake of the COVID-19 pandemicKatherine E Mues, Cindy Ke Zhou, Jennifer E Gerber, et al.
Acta Dermato-Venereologica|January 28, 2022
Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance CenterLinda Davidson, Juul M P A Van den Reek, Florence Van Hunsel, et al.
British Journal of Clinical Pharmacology|May 31, 2020
Opportunities for changes in the drug product design to enhance medication safety in older people: Evaluation of a national public portal for medication incidentsFatma Karapinar-Çarkit, Patricia M L A van den Bemt, Mariam Sadik, et al.
Drug Safety|January 14, 2026
Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus GroupFlorence van Hunsel, Samantha Lane, Dawn Cooper, et al.
Pageof 10